Loading…
Based on limited available metadata, the FDA issued a warning letter to Goran Pharma Pvt Ltd, a pharmaceutical company, on April 24, 2018. While the specific violations cannot be determined from the metadata provided, the letter addresses compliance concerns related to pharmaceutical manufacturing or operations. The exact regulatory scope and specific product category remain unclear due to incomplete records, though the warning indicates the company operates under FDA jurisdiction and oversight.